- Home
- CNTA vs VTMX Comparison
CNTA vs VTMX Comparison
Compare CNTA & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | VTMX |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | United Kingdom | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 3.2B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CNTA | VTMX |
|---|---|---|
| Price | $39.80 | $34.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $43.17 | $40.00 |
| AVG Volume (30 Days) | ★ 1.2M | 106.8K |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | $12.22 |
| Revenue Next Year | N/A | $11.52 |
| P/E Ratio | ★ N/A | $47.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.30 | $24.99 |
| 52 Week High | $40.26 | $37.41 |
Technical Indicators
Market Signals| Indicator | CNTA | VTMX |
|---|---|---|
| Relative Strength Index (RSI) | 63.14 | 48.12 |
| Support Level | $39.36 | $33.84 |
| Resistance Level | $39.90 | $36.96 |
| Average True Range (ATR) | 0.16 | 0.86 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 53.16 | 68.10 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.